Elliptinium

Drug profile

Key facts

Elliptinium is a drug catalogued in DrugCentral. DrugCentral lists 3 molecular targets, including KIT, FGFR3 and PDGFRA.

• Molecular targets: KIT, FGFR3 and PDGFRA (3 listed in DrugCentral).
• Molecular formula: C18H17N2O; molecular weight 277.35 g/mol.

Mechanism & targets

Molecular targets (3)

Target	Gene	Action	Activity
Mast/stem cell growth factor receptor Kit	KIT	unknown	IC50 6.40
Fibroblast growth factor receptor 3	FGFR3	unknown	IC50 6.30
Platelet-derived growth factor receptor alpha	PDGFRA	unknown	IC50 6.15

Chemical structure

• Molecular formula: C₁₈H₁₇N₂O
• Molecular weight: 277.35 g/mol
• CAS number: 58337-35-2
• InChIKey: YZQRAQOSAPWELU-UHFFFAOYSA-O
• PubChem CID: 42723

CC1=C2C=C[N+](C)=CC2=C(C)C2=C1NC1=CC=C(O)C=C21

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

How does Elliptinium work?

Its molecular targets in DrugCentral include KIT, FGFR3 and PDGFRA.

What is the chemical formula of Elliptinium?

Elliptinium has the molecular formula C18H17N2O and a molecular weight of 277.35 g/mol.

Sources

• DrugCentral drug card 996 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
• ChEMBL CHEMBL16699 — compound record and bioactivity
• PubChem CID 42723 — chemical identifiers
• FDA UNII 1F1959S062 — substance identity
• UniProt P10721 (KIT) — target protein
• UniProt P22607 (FGFR3) — target protein
• UniProt P16234 (PDGFRA) — target protein

How this page is built: methodology · editorial policy & corrections.